High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year StudyMartha Skinner, Daniel G. Wright, Kathleen T. Finn et al.|Annals of Internal Medicine|2004Cited by 615
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsMaría Teresa Cibeira, Martha Skinner, Vaishali Sanchorawala et al.|Blood|2011Cited by 288
Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapyÉlie Choufani, David C. Seldin, Vaishali Sanchorawala et al.|Blood|2001Cited by 230
A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high‐titer ABO antibodiesKaren Quillen, Willy A. Flegel, Sherry L. Sheldon et al.|Transfusion|2010Cited by 71